#Canada #Hair Loss #FoLix™ #Lumenis #Yokne'am Illit

Introduction

Lumenis Be. Ltd. has made news by expanding its groundbreaking laser treatment, FoLix™, to Canada, following significant earlier success in the United States. This innovation is not just a triumph for the company but also a huge win for patients seeking effective hair loss solutions. This launch marks a pivotal moment, especially as FoLix™ has recently garnered the title of ‘Best Laser Treatment for Hair Loss’ in NewBeauty’s 2025 Beauty Awards, highlighting its effectiveness and innovative technology.

FoLix™: A Revolutionary Solution

FoLix™ is a unique non-ablative fractional laser treatment designed to address hair loss, utilizing a technology that is the first of its kind approved by the FDA. The device works by delivering advanced laser pulses that stimulate hair follicles and enhance blood flow, promoting hair rejuvenation without any need for surgery or invasive procedures. With results typically visible after just four to six monthly sessions, FoLix™ stands out as a non-invasive solution against hair loss.

The treatment is safe and requires no significant recovery time, making it an appealing option for both men and women. According to estimations, over 85% of men and 50% of women experience some degree of hair loss in their lifetimes, contributing to emotional distress and diminished self-esteem. Thus, the availability of FoLix™ serves as an essential step towards improving personal confidence and quality of life for many.

Recognition and Expansion

The recognition from NewBeauty reinforces FoLix™'s status in the market as a top choice among hair loss solutions. Tzipi Ozer-Armon, CEO of Lumenis, stated, “With FoLix, we're not just offering a treatment—we're empowering people to reclaim their confidence.” The NewBeauty award is particularly significant as it reflects both patient satisfaction and clinical effectiveness, underscoring Lumenis's commitment to provide reliable, science-backed aesthetic solutions.

The expansion into the Canadian market is expected to strengthen the presence of FoLix™ globally. Lumenis aims to accelerate access to this cutting-edge treatment, paving the way for patients outside of the United States to benefit from this innovative solution. The momentum originating from the NewBeauty award will likely contribute to Lumenis's efforts in reaching even more international markets in the near future.

Understanding the Technology

FoLix™ operates using proprietary technology that is specifically designed for scalp treatments. Its safe application ensures that patients will not experience invasive procedures like needles or anesthesia, alleviating common anxieties associated with hair restoration treatments. By stimulating natural healing processes within the body, FoLix™ promotes tissue regeneration—a key factor in achieving hair growth.

As the hair loss industry continues to evolve, patients are increasingly leaning towards non-surgical options, particularly those that align comfortably with their lifestyles. FoLix™ directly addresses this growing demand, capturing interest from a diverse demographic looking for effective yet convenient hair loss solutions.

Final Thoughts

With its recent expansion into Canada, Lumenis is poised to revolutionize the hair loss treatment landscape further. The company’s long-standing expertise in developing and commercializing energy-based medical devices uniquely positions it to meet the needs of a growing market. More patients now have access to safe, effective, and scientifically validated solutions for hair loss, empowering them to feel their best.

As Lumenis forges ahead, further product innovations and expansions can be anticipated, promising exciting advancements in aesthetic and therapeutic options for individuals facing hair loss.